Garrett Lindemann, Ph.D., Joins Kyield As Executive Vice President And Chief Scientific Officer For Life Sciences

Dr. Lindemann to Lead Strategic Partnerships and Licensing in Life Sciences and Healthcare

SANTA FE, N.M.--(BUSINESS WIRE)--Kyield, a pioneer in data management and artificial intelligence systems, announced today that industry veteran Garrett W. Lindemann, Ph.D., has joined the company as Executive Vice President and Chief Scientific Officer for Life Sciences. In this role, Dr. Lindemann will be responsible for leading strategic business development, licensing, and partnerships in biotech, pharmaceuticals, diagnostics, devices, and healthcare.

“I am excited to lead the effort in bringing this innovative technology to life science companies, healthcare providers, and patients.”

“Garrett has a strong background in identifying and assisting revolutionary technology to facilitate the commercialization and advancement of diagnostics and therapies,” said Mark A. Montgomery, Founder and CEO of Kyield. “His breadth and depth in science and industry will be important in forging enduring partnerships to leverage our systems technology for accelerating discoveries and delivering precision medicine.”

Dr. Lindemann brings 20 years of experience in life sciences to this role. He started his career at Boehringer Mannheim in 1995, which was acquired by Roche in 1997, where he managed and led research teams and performed technology assessment for the Chief Technology Office of Roche Diagnostics. He then served as Executive Vice President of Research and Development for a start-up pharmaceutical company with responsibility for molecule and drug development (pre-clinical and clinical) and patent portfolio management, before joining Initium Venture Capital as Life Sciences Analyst. More recently Dr. Lindemann has served as a consultant and advisor to multiple biotech and pharmaceutical companies, Kyield, and the University of Wyoming.

“Kyield offers a data management platform with a patented artificial intelligence system, representing a rare opportunity to accelerate scientific discovery and provide deeply tailored precision medicine,” said Dr. Lindemann. “I am excited to lead the effort in bringing this innovative technology to life science companies, healthcare providers, and patients.”

Dr. Lindemann earned his undergraduate degree in Biology from Saint John’s University (Collegeville, Minnesota), and was awarded a Ph.D. in Molecular Genetics from the University of Kansas (Lawrence, Kansas) in 1995.

About Kyield

Kyield offers a distributed operating system for achieving optimal yield of executable knowledge across large data networks. The patented AI system core acts to unify networks with adaptive data tailored to each entity, with continuous predictive analytics designed to significantly reduce ongoing costs while accelerating productivity. For more information, please visit www.kyield.com.

Help employers find you! Check out all the jobs and post your resume.